E.T. Edgell

1.9k total citations
48 papers, 1.5k citations indexed

About

E.T. Edgell is a scholar working on Psychiatry and Mental health, Economics and Econometrics and Pharmacology. According to data from OpenAlex, E.T. Edgell has authored 48 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Psychiatry and Mental health, 15 papers in Economics and Econometrics and 9 papers in Pharmacology. Recurrent topics in E.T. Edgell's work include Schizophrenia research and treatment (27 papers), Bipolar Disorder and Treatment (16 papers) and Health Systems, Economic Evaluations, Quality of Life (14 papers). E.T. Edgell is often cited by papers focused on Schizophrenia research and treatment (27 papers), Bipolar Disorder and Treatment (16 papers) and Health Systems, Economic Evaluations, Quality of Life (14 papers). E.T. Edgell collaborates with scholars based in United States, United Kingdom and Spain. E.T. Edgell's co-authors include Dennis A. Revicki, Josep María Haro, S.H. Hamilton, Gian Gandhi, Jordi Alonso, Alan Breier, Diego Novick, Ana Lowin, Emuella Flood and Leah Kleinman and has published in prestigious journals such as Medical Care, Schizophrenia Research and Osteoporosis International.

In The Last Decade

E.T. Edgell

46 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.T. Edgell United States 23 1.0k 287 260 213 166 48 1.5k
Amy Grogg United States 13 865 0.8× 117 0.4× 201 0.8× 121 0.6× 79 0.5× 26 1.2k
Joëlle A. Erkens Netherlands 17 272 0.3× 101 0.4× 260 1.0× 20 0.1× 98 0.6× 25 1.2k
Karen P. Hayhurst United Kingdom 15 1.3k 1.2× 237 0.8× 335 1.3× 382 1.8× 49 0.3× 38 1.7k
A. David Mangelsdorff United States 11 484 0.5× 52 0.2× 184 0.7× 161 0.8× 98 0.6× 44 1.2k
Hassan Alinaghizadeh Sweden 16 463 0.5× 34 0.1× 215 0.8× 82 0.4× 60 0.4× 28 1.1k
Annette H. Blankenstein Netherlands 20 532 0.5× 61 0.2× 104 0.4× 161 0.8× 35 0.2× 46 1.1k
Jaume Aguado Spain 22 609 0.6× 57 0.2× 457 1.8× 67 0.3× 55 0.3× 50 1.4k
David K. Baugh United States 7 268 0.3× 185 0.6× 64 0.2× 8 0.0× 145 0.9× 23 968
Keita Yamauchi Japan 19 267 0.3× 55 0.2× 222 0.9× 44 0.2× 41 0.2× 75 1.0k
Catherine Woodman United States 20 355 0.3× 77 0.3× 317 1.2× 76 0.4× 80 0.5× 37 1.3k

Countries citing papers authored by E.T. Edgell

Since Specialization
Citations

This map shows the geographic impact of E.T. Edgell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.T. Edgell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.T. Edgell more than expected).

Fields of papers citing papers by E.T. Edgell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.T. Edgell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.T. Edgell. The network helps show where E.T. Edgell may publish in the future.

Co-authorship network of co-authors of E.T. Edgell

This figure shows the co-authorship network connecting the top 25 collaborators of E.T. Edgell. A scholar is included among the top collaborators of E.T. Edgell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.T. Edgell. E.T. Edgell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kozma, Chris M, et al.. (2013). Cost and utilization of healthcare services for hip and knee replacement. Journal of Medical Economics. 16(7). 888–896. 31 indexed citations
2.
Birnbaum, Howard G., et al.. (2010). Economic burden of privately insured non-vertebral fracture patients with osteoporosis over a 2-year period in the US. Osteoporosis International. 22(1). 47–56. 26 indexed citations
3.
Pike, Crystal, et al.. (2010). Direct and Indirect Costs of Non-Vertebral Fracture Patients with Osteoporosis in the US. PharmacoEconomics. 28(5). 395–409. 114 indexed citations
4.
Pike, Crystal, Howard G. Birnbaum, M. Schiller, et al.. (2010). Prevalence and costs of osteoporotic patients with subsequent non-vertebral fractures in the US. Osteoporosis International. 22(10). 2611–2621. 26 indexed citations
5.
Edgell, E.T., et al.. (2010). Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States. Journal of Medical Economics. 13(3). 393–402. 40 indexed citations
6.
Ahn, Jeonghoon, Jeffrey S. McCombs, Tim Croudace, et al.. (2007). Classifying Patients by Antipsychotic Adherence Patterns Using Latent Class Analysis: Characteristics of Nonadherent Groups in the California Medicaid (Medi-Cal) Program. Value in Health. 11(1). 48–56. 56 indexed citations
7.
Shi, Lizheng, et al.. (2006). Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes. Current Medical Research and Opinion. 22(5). 961–966. 13 indexed citations
8.
Novick, Diego, Manuel Bousoño, David L. Suarez, et al.. (2005). Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: Results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 29(6). 972–982. 25 indexed citations
9.
Haro, Josep María, E.T. Edgell, Diego Novick, et al.. (2004). Effectiveness of antipsychotic treatment for schizophrenia: 6‐month results of the Pan‐European Schizophrenia Outpatient Health Outcomes (SOHO) study. Acta Psychiatrica Scandinavica. 111(3). 220–231. 82 indexed citations
10.
11.
Knapp, Martín, et al.. (2003). Unit costs in international economic evaluations: resource costing of the Schizophrenia Outpatient Health Outcomes Study. Acta Psychiatrica Scandinavica. 107(s416). 41–47. 8 indexed citations
12.
Prieto, Luis, et al.. (2003). A Rasch model analysis to test the cross‐cultural validity of the EuroQoL‐5D in the Schizophrenia Outpatient Health Outcomes Study. Acta Psychiatrica Scandinavica. 107(s416). 24–29. 61 indexed citations
13.
Dardennes, Roland, Hélène Verdoux, Gian Gandhi, et al.. (2003). Frequency of Hospitalisations and Inpatient Care Costs of Manic Episodes. PharmacoEconomics. 21(15). 1081–1090. 27 indexed citations
14.
Haro, Josep María, E.T. Edgell, Peter B. Jones, et al.. (2003). The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment. Acta Psychiatrica Scandinavica. 107(3). 222–232. 96 indexed citations
15.
Kleinman, Leah, Ana Lowin, Emuella Flood, et al.. (2003). Costs of Bipolar Disorder. PharmacoEconomics. 21(9). 601–622. 177 indexed citations
16.
Shi, Lizheng, M. Namjoshi, Gian Gandhi, et al.. (2002). Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. International Clinical Psychopharmacology. 17(5). 227–237. 54 indexed citations
17.
18.
Edgell, E.T., Timothy R. Hylan, JoLaine R. Draugalis, & Stephen Joel Coons. (2000). Initial Treatment Choice in Depression. PharmacoEconomics. 17(4). 371–382. 4 indexed citations
19.
Edgell, E.T., et al.. (1999). A Framework for Drug Utilization Evaluation in Depression. Medical Care. 37(4 Suppl Lilly). AS67–AS76. 10 indexed citations
20.
Edgell, E.T., et al.. (1997). Well-Being and Functional Status of Pharmacy Students: A Preliminary Assessment. Journal of Pharmacy Technology. 13(2). 84–88. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amy Grogg Breakdown of academic impact, for papers by Joëlle A. Erkens Breakdown of academic impact, for papers by Karen P. Hayhurst Breakdown of academic impact, for papers by A. David Mangelsdorff Breakdown of academic impact, for papers by Hassan Alinaghizadeh Breakdown of academic impact, for papers by Annette H. Blankenstein Breakdown of academic impact, for papers by Jaume Aguado Breakdown of academic impact, for papers by David K. Baugh Breakdown of academic impact, for papers by Keita Yamauchi Breakdown of academic impact, for papers by Catherine Woodman
Rankless by CCL
2026